Lee Scott Golden insider trades

Open-market stock purchases and sales by Lee Scott Golden, Director at Cadrenal Therapeutics, Inc, from SEC Form 4 filings since Oct 5, 2016.

Recent trades

DateStockTradeValue
Oct 9, 2026CVKD Cadrenal Therapeutics, IncBought (not open market)—
Apr 2, 2026PTCT PTC Therapeutics, IncSold$56.4K
Mar 5, 2026PTCT PTC Therapeutics, IncSold$634K
Feb 18, 2026PTCT PTC Therapeutics, IncSold$172K
Jan 8, 2026PTCT PTC Therapeutics, IncSold$66.2K
Jan 7, 2026PTCT PTC Therapeutics, IncSold$49.7K
Jan 6, 2026PTCT PTC Therapeutics, IncSold$103K
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Dec 2, 2025CVKD Cadrenal Therapeutics, IncBought (not open market)—

Companies traded

  • CVKD Cadrenal Therapeutics, Inc: other filings, last Oct 9, 2026
  • PTCT PTC Therapeutics, Inc: 15 sales, last Apr 2, 2026
  • GEMP Gemphire Therapeutics Inc: other filings, last Jan 28, 2018

Get free alerts when Lee Scott Golden files a new trade →